LEADERSHIP

The HPP EC is responsible for making all decisions that are related to the development of the HPP. It stimulates productive developments and interconnections among the components of the HPP and with the broader genomics and life sciences communities. It ensures the implementation of guidelines proposed for the three pillars and the two programs of the HPP. It ratifies new teams in the C-HPP and B/D-HPP programs proposed by the EC and PI Council of each. It oversees and stimulates publications identified as products of the HPP Consortium.

• Robert Moritz, Chair (2020-2021)
• Co-chair - Open (2021-2022)
• Charles Pineau, Incoming Chair, HPP Website Coordinator
• Gil Omenn, Emeritus
• Yu-Ju Chen, Incoming President
• Ruedi Aebersold, Scientific Advisory Board Chair
• Chris Overall, C-HPP Chair
• Young-Ki Paik, C-HPP Co-Chair
• Lydie Lane, C-HPP Co-chair
• Ileana Cristea, B/D-HPP Chair
• Fernando Corrales, B/D-HPP Past Chair
• Siqi Liu, Asia/Oceania Member-at-Large
• Eric Deutsch, Knowledgebase Resource Pillar Chair
• Susan Weintraub, Mass Spectrometry Resource Pillar Chair
• Cecilia Lindskog Bergström, Antibody Resource Pillar Chair
• Michael Roehrl, Pathology Pillar Chair

The SSAB is composed of up to 12 members with three-year terms that are renewable. They are internationally recognized scientists who are directly or indirectly involved in proteomics research or have expertise in relevant fields outside the proteomics community. Nominations of SSAB members can be made by the HPP General Assembly Members and ratified by the HPP EC. The SSAB will be convened annually at the HUPO Congress and at other times either by conference call or in conjunction with a major proteomics meeting.

• Ruedi Aebersold, Chair
• Subhra Chakraborty
• Anne-Claude Gingras
• Fuchu He
• Kathryn Lilley
• Emma Lundberg
• Anthony Purcell
• John Yates III